biotinylated vvl 536 (Vector Laboratories)
Structured Review
Biotinylated Vvl 536, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 167 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/B-1235-2/Biotinylated+Vicia+Villosa+Lectin+(VVL%2C+VVA)/pm42024456-237-3-8
Average 95 stars, based on 167 article reviews
Images
Related Articles
Isolation:Article Title: Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity. Article Snippet: INTRODUCTION: Macrophages in the tumor microenvironment exert antitumorigenic effects through phagocytosis and/or direct tumoricidal activity.. Phagocytosis of tumor cells occurs through both antibodydependent cellular phagocytosis (ADCP) and antibodyindependent cellular phagocytosis (AICP) mechanisms.. Despite the strong evidence that macrophages can mediate tumor control in acute myeloid leukemia (AML) and other diseases, therapeutic agents that enhance macrophage phagocytosis, including antiCD47 neutralizing antibodies, have not led to improved clinical outcomes. Staining:Article Title: Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity. Article Snippet: INTRODUCTION: Macrophages in the tumor microenvironment exert antitumorigenic effects through phagocytosis and/or direct tumoricidal activity.. Phagocytosis of tumor cells occurs through both antibodydependent cellular phagocytosis (ADCP) and antibodyindependent cellular phagocytosis (AICP) mechanisms.. Despite the strong evidence that macrophages can mediate tumor control in acute myeloid leukemia (AML) and other diseases, therapeutic agents that enhance macrophage phagocytosis, including antiCD47 neutralizing antibodies, have not led to improved clinical outcomes. Article Title: GALNT1 drives aggressive phenotypes of rheumatoid synoviocytes via NEK9 O‑glycosylation. Article Snippet: For the staining of GALNT1 or NEK9, 560 anti-GALNT1 (1:50, HPA012628, Sigma-Aldrich, USA, polyclonal antibody) or anti-561 NEK9 (1:50, sc-100401, Santa Cruz, USA, clone: 39-7) was utilized. .. For VVL 562 staining, Incubation:Article Title: GALNT1 emerges as a potential therapeutic target in breast cancer Article Snippet: HRP-conjugated goat anti-rabbit IgG (1:5000, SA00001-2, Proteintech) was applied for 1 h at room temperature. .. To detect O-glycosylated proteins, membranes were incubated overnight with Article Title: GALNT1 emerges as a potential therapeutic target in breast cancer. Article Snippet: HRP-conjugated goat anti-rabbit IgG (1:5000, SA00001-2, Proteintech) was applied for 1 h at room temperature. .. To detect O-glycosylated proteins, membranes were incubated overnight with Article Title: Abnormal glycosylation of MUC20 mediates TAM polarization and promotes immune escape in colorectal cancer. Article Snippet: .. 4 μg of Article Title: GALNT1 emerges as a potential therapeutic target in breast cancer Article Snippet: .. Samples were incubated overnight at 4 °C with anti-GALNT1 (1:200, 21139-1-AP, Proteintech), anti-PDI (1:200, #222581, Zenbio), anti-FAP (1:200, #222271, Zenbio), or |
